MTAF-DTA:多种类型的注意力融合网络,用于药物向 afinity 预测
Jinghong Sun1, Han Wang1, Jia Mi1
1College of Information Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China.
BMC bioinformatics
|December 5, 2024
概括
这项研究介绍了MTAF-DTA,这是一种用于预测药物标结合亲和力 (DTA) 的新型AI方法. 通过模拟药物向相互作用和解决现有模型中的信息丢失,MTAF-DTA提高了预测准确性.
科学领域:
- 计算化学是一种计算化学.
- 人工智能在药物发现中的作用
- 生物信息学是一种生物信息学.
背景情况:
- 药物标结合亲和力 (DTA) 的预测对于加速药物发现至关重要.
- 机器学习模型越来越多地用于DTA预测,比传统方法提供效率.
- 现有的DTA预测方法存在药物信息丢失,未加权的特征贡献和缺乏结合机制模拟的问题.
研究的目的:
- 开发一种先进的人工智能驱动的方法,用于准确的药物标结合亲和力预测.
- 克服当前DTA预测模型的局限性,包括信息丢失和绑定机制的模拟不足.
- 提高药物发现管道的效率和可靠性.
主要方法:
- 拟议的MTAF-DTA,是一种用于DTA预测的新方法.
- 采用了具有注意力机制的药物表示模块,以更新三种模式的特征贡献权重.
- 引入了螺旋注意力区块 (SAB),用于基于注意力的多种类型的药物向特征融合,模拟结合相互作用.
主要成果:
- 在戴维斯和KIBA数据集上,MTAF-DTA表现出卓越的预测性能.
- 在新的目标设置中,与最先进的方法相比,在一致性指数 (CI) 中取得了1.1%的改善,在平均平方误差 (MSE) 中获得了9.2%的改善.
- 下游任务进一步验证了该方法在DTA预测中的有效性.
结论:
- MTAF-DTA显著提高了药物标结合 afinity 预测的准确性.
- 该方法模拟结合机制和整合多模式特征的能力显示了实践药物发现的巨大潜力.
- 结果表明MTAF-DTA在药物发现和疾病治疗等应用中的实用性.
更多相关视频
相关概念视频
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K


